Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IGFBPs and cancer.

Peng Fang1, Vivian Hwa, Ron Rosenfeld

  • 1Department of Pediatrics, Oregon Health & Science University, Portland, OR 97239-3098, USA.

Novartis Foundation Symposium
|November 26, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Open-Label 9-Year Follow-Up Extension Phase 2 Study of Once-Weekly Somatrogon in Children With Growth Hormone Deficiency.

The Journal of clinical endocrinology and metabolism·2026
Same author

Discrimination of generalized anxiety and major depressive disorders by machine learning of resting-state functional MRI.

BMC psychiatry·2026
Same author

Functional characterization of four glycosyltransferases for biosynthesis of steroidal saponins in medicinal plant <i>Paris polyphylla</i>.

Synthetic and systems biotechnology·2026
Same author

Smartphone-based motion capture for gait quantification and symmetry analysis in moderate-stage stroke patients.

Gait & posture·2026
Same author

Association of Complete Blood Count-Derived Inflammatory Markers with Trouble Sleeping: Evidence from Population Data and Experimental Sleep Deprivation.

Nature and science of sleep·2026
Same author

Reduced sleep efficiency leads to cognitive dysfunction in major depressive disorder via disrupting fronto-visual circuit functional connectivity.

Journal of affective disorders·2026
Same journal

Genetic and therapeutic control of diabetogenic CD8+ T cells.

Novartis Foundation symposium·2009
Same journal

Translating mucosal antigen based prevention of autoimmune diabetes to human.

Novartis Foundation symposium·2009
Same journal

Re-establishing immune tolerance in type 1 diabetes via regulatory T cells.

Novartis Foundation symposium·2009
Same journal

Immune markers of disease and therapeutic intervention in type 1 diabetes.

Novartis Foundation symposium·2009
Same journal

Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell mass.

Novartis Foundation symposium·2009
Same journal

CD8 and cytotoxic T cells in type 1 diabetes.

Novartis Foundation symposium·2009
See all related articles

Insulin-like growth factor binding proteins (IGFBP) are a protein superfamily. IGFBP-3 shows potential protective effects against cancer through both IGF-dependent and IGF-independent mechanisms.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • The insulin-like growth factor binding protein (IGFBP) superfamily comprises secreted proteins with structural, functional, and evolutionary links.
  • This superfamily includes six IGFBPs and over 10 related proteins, all exhibiting high affinity for insulin-like growth factors (IGFs).
  • IGFBPs modulate IGF actions and possess independent anti-proliferative and pro-apoptotic functions, particularly IGFBP-3.

Purpose of the Study:

  • To explore the potential role of IGFBP-3 in cancer risk and its underlying mechanisms.
  • To investigate both IGF-dependent and IGF-independent pathways through which IGFBP-3 may exert protective effects.
  • To assess the clinical relevance of IGFBP's cancer cell proliferation inhibition observed in vitro.

Main Methods:

Related Experiment Videos

  • Review of epidemiological data correlating serum IGF/IGFBP levels with cancer risk.
  • Analysis of in vitro studies examining the functions of IGFBP-3.
  • Examination of IGF-dependent and IGF-independent mechanisms of IGFBP-3 action.

Main Results:

  • Epidemiological data suggest a potential protective role for IGFBP-3 in human cancers.
  • In vitro studies indicate that IGFBP-3's protective effects involve both IGF-dependent and IGF-independent mechanisms.
  • IGFBPs, especially IGFBP-3, demonstrate anti-proliferative and pro-apoptotic functions independent of IGFs.

Conclusions:

  • IGFBP-3 may play a protective role in cancer, acting through multiple mechanisms.
  • Further research is required to confirm the clinical significance of IGFBP-3's anti-cancer properties.
  • The modulation of IGFBPs by proteolysis is a key factor in their function.